Skip to main content
Signal8

Orgenesis Inc. (ORGS)

Sector: Biotechnology

Industry: Biotechnology

Orgenesis Inc. logo

Orgenesis Inc.

OTC:ORGSHealthcare
-12.00%$0.3300
CLOSED
Mkt Cap$1.71M
EV-
Float3.97M
O/S5.17M
VOL1K sh
$ Vol$405
RVOL0.71×
Inst Own1.0%
SI0.1%
Net Cash/Sh-
Dilution
Orgenesis Inc. logoOTC:ORGSClosed$0.3300-12.00%
Historical Data
DateOpenHighLowCloseVolume
Nov 16, 20260.30000.33000.30000.33001,262
Nov 13, 20260.37500.37500.37500.3750110
Nov 12, 20260.30000.30000.30000.3000100
Nov 11, 20260.34560.34560.30000.3000429
Nov 10, 20260.30000.30000.30000.3000100
Nov 9, 20260.35000.35000.35000.3500100
Nov 6, 20260.35000.35000.35000.3500100
Nov 5, 20260.49000.49000.40000.4000900
Nov 4, 20260.49000.49000.49000.4900100
Nov 2, 20260.04670.04670.04670.0467104
Oct 30, 20260.05000.40000.02800.02806,300
Oct 27, 20260.04670.32500.04670.04672,611
Oct 22, 20260.04670.40000.04670.40005,100
Oct 15, 20260.05670.05670.05670.05672,524
Oct 13, 20260.07000.07000.07000.070017,615
Oct 6, 20260.35000.35000.35000.3500200
Oct 5, 20260.55000.55000.55000.5500100
Oct 2, 20260.06670.58000.06670.5800357
Analyst Coverage
Analyst Coverage
ConsensusBuy
Price Target
Not available
Ratings Distribution
BUY
1
HOLD
0
SELL
0
TOTAL1
Insider Trades
InsiderTypeShares
Nanda Ashish profile photoNanda AshishGrant/Award1.8K
BHALAJI JAGANNATHAN profile photoBHALAJI JAGANNATHANGrant/Award1.3K
BHALAJI JAGANNATHAN profile photoBHALAJI JAGANNATHANGrant/Award625
Vider Itzhak profile photoVider ItzhakGrant/Award1.5K
NAGARAJ SANTHOSH profile photoNAGARAJ SANTHOSHGrant/Award1.3K
NAGARAJ SANTHOSH profile photoNAGARAJ SANTHOSHGrant/Award625
Shareholders
1.0%
Institutional
(1)
0.0%
Insiderⓘ
(0)
24.2%
5%+ Owners
(2)
74.8%
Unattributed (incl. retail)ⓘ
Institutional1.0%
5%+ Beneficial24.2%
Unattributed (incl. retail)74.8%
Top Shareholders
NameShares%
Neurocords LLC logo
Neurocords LLC
· may incl. warrants· filed Mar 2025
1.2M23.2%
JACOB SAFIER logo
JACOB SAFIER
· may incl. warrants· filed Dec 2024
51.6K1.0%
Knoll Capital Management, LLC logo
Knoll Capital Management, LLC
50.6K1.0%
Sources: 13F, Form 4, 13D/13GO/S: 5.2M · checked 8 Oct 2026 · market-data provider
Insiders & Institutional Holders

Insiders

Top institutional holders

About

Orgenesis Inc. is a global biotechnology firm dedicated to the field of cell and gene therapies.

The company has engineered an innovative Point of Care (POCare) platform. This system incorporates a portfolio of licensed POCare therapeutics, which are manufactured and prepared using automated, self-contained POCare technology within a cooperative network. Orgenesis primarily concentrates on autologous therapies, developing customized processes and systems for each treatment. These utilize a closed, automated processing methodology, validated for safe and compliant production directly at the patient's location, facilitating immediate therapeutic application. Established in 2008 as Business Outsourcing Service, Inc., the company adopted the name Orgenesis Inc. in August 2011 and is headquartered in Germantown, Maryland.

Key Metrics
Market Cap$1.71M
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership0.98%

based on 5.17M shares outstanding

SectorHealthcare
IndustryBiotechnology
ExchangeOTC
CountryUSUS
IPO DateMar 13, 2012
Shares Outstanding5.17M
Authorized Shares
Float3.97M
52-Week Range
$0.0001$0.8450
$0.3300(39th percentile)
Volume
Average Daily Volume1.79K
1.26K today vs 1.79K avg(-29%)

30d Avg

1.79K

60d Avg

1.61K

90d Avg

1.35K

Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...

Orgenesis Inc. (OTC: ORGS) traded at $0.3300 on Nov 16, 2026, down 12.00% from the previous close of $0.3750. 52-week range: $0.0001 to $0.8450. The company is in the Healthcare sector (Biotechnology).